Trittico retard 150 mg

Trittico is a well-known pharmaceutical brand containing the active ingredient Trazodone, used primarily as an antidepressant with sedative properties. The brand was originally developed in Italy by Angelini Pharma (Francesco Angelini), which remains the primary innovator and producer of the medication. The 'retard' designation on this specific packaging indicates a prolonged-release formulation, common in European pharmaceutical markets.

While maintenance of the brand is primarily handled by the Italian parent company, production and distribution occur across several European and international facilities. As of 2024 and beyond, Angelini Pharma continues to be the ultimate owner, maintaining its headquarters in Rome and operating as a major player in the global CNS (Central Nervous System) healthcare sector.